Click Therapeutics Revenue and Competitors

Claim your profile



Growjo Ranking



Estimated Revenue & Valuation

  • Click Therapeutics's estimated annual revenue is currently $29.3M per year.(i)
  • Click Therapeutics received $17.0M in venture funding in July 2018.
  • Click Therapeutics's estimated revenue per employee is $193,750
  • Click Therapeutics's total funding is $911.4M.

Employee Data

  • Click Therapeutics has 151 Employees.(i)
  • Click Therapeutics grew their employee count by 10% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click's Digital Therapeutics enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click's industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click's lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Click Therapeutics News

2022-04-17 - Biofourmis reaches unicorn status with $300M Series D

AI-backed remote monitoring and digital therapeutics company Biofourmis raised a ... Happify Health, Big Health and Click Therapeutics.

2022-04-06 - Click Therapeutics Closes $15 Million Debt Financing from ...

(“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that it has secured a $15 million term loan...

2022-03-30 - Click Therapeutics to Present at Chardan's Prescription Digital ...

(“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that Randall Stanicky, Chief Financial Officer,...

2021-10-25 - Click Therapeutics lands $52M

Click Therapeutics has raised a $52 million Series B co-led by Accelmed and HIG BioHealth Partners. The New York-based company develops digital prescription medical treatments for patients with chronic pain, autoimmune disorders and other health conditions. Additional Investors Health Catalyst ...

2021-10-25 - Click Therapeutics raises $52M, looks to advance digital therapeutics

Less than a year after its last financing, Click Therapeutics raised $52 million to develop its portfolio of software-based treatments. The New York-based startup recently raised a series B round led by H.I.G. BioHealth Partners and Accelmed Partners II. Sanofi, an early investor in the company, ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

Click Therapeutics Funding

DateAmountRoundLead InvestorsReference
2018-07-24$17.0MUndisclosedSanofi VenturesArticle